Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Cox Gill

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Thrombosis Research|May 11, 2007
Treatment of urgent bleeding in von Willebrand diseaseJoan Cox Gill
Hematology/Oncology Clinics of North America|October 30, 2004
Diagnosis and treatment of von Willebrand diseaseJoan Cox Gill
Current Treatment Options in Cardiovascular Medicine|January 7, 2014
Approach to acute ischemic stroke in childhoodCatherine Amlie-Lefond, Joan Cox Gill
Seminars in Pediatric Neurology|December 25, 2010
Pharmacology in childhood arterial ischemic strokeCatherine Amlie-Lefond, Joan Cox Gill
The Journal of Pediatrics|May 29, 2002
Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand diseaseJoan Cox Gill, Marilyn Ottum, Bruce Schwartz
Blood|February 11, 2017
Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance projectMarilyn J Manco-Johnson, J Michael Soucie, Joan Cox Gill, et al.
Future Virology|January 15, 2014
CD4<sup>+</sup> T-cell engagement by both wild-type and variant HCV peptides modulates the conversion of viral clearing helper T cells to TregsMatthew F Cusick, Jane E Libbey, Joan Cox Gill, et al.
Blood Transfusion = Trasfusione Del Sangue|June 6, 2013
Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrand's disease undergoing elective surgery: a pooled and comparative analysis of data from USA and European Union clinical trialsPier Mannuccio Mannucci, Paul Alexander Kyrle, Sam Schulman, et al.
Seminars in Thrombosis and Hemostasis|November 22, 2011
Von Willebrand disease in the United States: a perspective from WisconsinVeronica H Flood, Joan Cox Gill, Kenneth D Friedman, et al.
Blood|March 21, 2012
Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storagePaula M Jacobi, Joan Cox Gill, Veronica H Flood, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Thrombosis Research|May 11, 2007
Treatment of urgent bleeding in von Willebrand diseaseJoan Cox Gill
Hematology/Oncology Clinics of North America|October 30, 2004
Diagnosis and treatment of von Willebrand diseaseJoan Cox Gill
Current Treatment Options in Cardiovascular Medicine|January 7, 2014
Approach to acute ischemic stroke in childhoodCatherine Amlie-Lefond, Joan Cox Gill
Seminars in Pediatric Neurology|December 25, 2010
Pharmacology in childhood arterial ischemic strokeCatherine Amlie-Lefond, Joan Cox Gill
The Journal of Pediatrics|May 29, 2002
Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand diseaseJoan Cox Gill, Marilyn Ottum, Bruce Schwartz
Blood|February 11, 2017
Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance projectMarilyn J Manco-Johnson, J Michael Soucie, Joan Cox Gill, et al.
Future Virology|January 15, 2014
CD4<sup>+</sup> T-cell engagement by both wild-type and variant HCV peptides modulates the conversion of viral clearing helper T cells to TregsMatthew F Cusick, Jane E Libbey, Joan Cox Gill, et al.
Blood Transfusion = Trasfusione Del Sangue|June 6, 2013
Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrand's disease undergoing elective surgery: a pooled and comparative analysis of data from USA and European Union clinical trialsPier Mannuccio Mannucci, Paul Alexander Kyrle, Sam Schulman, et al.
Seminars in Thrombosis and Hemostasis|November 22, 2011
Von Willebrand disease in the United States: a perspective from WisconsinVeronica H Flood, Joan Cox Gill, Kenneth D Friedman, et al.
Blood|March 21, 2012
Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storagePaula M Jacobi, Joan Cox Gill, Veronica H Flood, et al.
Pageof 3